Primary Faculty
Mushui Dai, M.D., Ph.D.
Assistant Professor
daim@ohsu.edu
Our broad research interest is to understand the biological function and molecular mechanisms of the p53 tumor suppression and c-Myc oncogenic pathways, thereby providing a possible means to manipulate p53 and c-Myc function in cancer cells.
Full Bio
Melanie Gillingham, Ph.D., R.D.
Assistant Professor
gillingm@ohsu.edu
Our current work is focused on the treatment of rare disorders in the FAO pathway. Our future goal is to learn from these disorders about the role of fatty acid oxidation in body weight regulation and the development of insulin resistance.
Full Bio
Cary Harding, M.D.
Associate Professor
hardingc@ohsu.edu
Inborn errors of metabolism (IEM) affect as many as 1:1500 people with age of onset varying from birth to adulthood. For many of these disroders, contemporary medical therapy is less than satisfactory.
Full Bio
Susan Hayflick, M.D.
Professor and Chair
hayflick@ohsu.edu
Brain iron accumulates in many human neurodegenerative disorders, including Parkinson disease, Alzheimer disease
and HIV encephalopathy.
Full Bio
Kelly Hamman, M.S., C.G.C.
Instructor
hammank@ohsu.edu
Developed a special interest in genetics during her undergraduate studies. Based on her clinical and laboratory experiences, she decided to pursue a career in genetic counseling.
Full Bio
Monique Johnson, Ph.D.
Assistant Professor
johnsmon@ohsu.edu
The focus of my clinical research is the development of sequence-based testing for rare disorders, development of next generation sequencing panels for rare disorders,
Full Bio
Jessica Kushner, M.S., C.G.C.
Instructor
kushnerj@ohsu.edu
I really enjoy the specialty of Genetics as one that looks at a whole person as well as their family members. As a genetic counselor, helping people by providing important medical information and resources about rarely known genetic disease
Full Bio
R. Michael Liskay, Ph.D.
Professor
liskaym@ohsu.edu
We use yeast and mice to study DNA mismatch repair (MMR),which corrects mismatches and senses DNA damage. MMR gene mutations increase spontaneous mutation and predispose to hereditary and sporadic cancer.
Full Bio
Hiroyuki Nakai, M.D., Ph.D.
Associate Professor
nakaih@ohsu.edu
The major focuses of our laboratory are the elucidation of the biology of recombinant adeno-associated virus (rAAV) vectors and cellular biology associated with rAAV infection/transduction, and development of new rAAV vector-mediated gene and cell therapies to treat various human diseases.
Full Bio
Stephen R. Moore, Ph.D., FACMG
Assistant Professor
moorest@ohsu.eduLaboratory interests include chromosomal microarray analysis for congenital disorders, the development of sequencing-based tests and panels for rare genetic disorders, and the development of genomic tools.
Full Bio
Robb Moses, M.D.
Professor
mosesr@ohsu.edu
Dr. Moses` special areas of interest include Fanconi anemia, DNA repair deficiencies and gene therapy. He currently heads the Department of Molecular and Medical Genetics.
Full Bio
Susan Olson, Ph.D.
Professor
olsonsu@ohsu.edu
Chromosome aberrations contribute significantly to human disease. Close collaboration between our clinical and research cytogenetics laboratories contributes
Full Bio
Carolyn Sue Richards, Ph.D., FACMG
Professor
richarsu@ohsu.edu
The focus of my clinical research laboratory is development of sequence-based testing for rare disorders, development of custom analysis to address copy number variants,
Full Bio
Jone Sampson, Ph.D.
Assistant Professor
sampsojo@ohsu.eduDr. Sampson is a clinical geneticist specializing in cancer genetics. She enjoys working in this field because finding gene mutations in families with an inherited tendency for cancer can help save lives through prevention and early detection.
Full Bio
Rosalie Sears, Ph.D.
Professor
searsr@ohsu.edu
We are studying cellular signaling pathways involved in the generation of human cancer. In general, disruption of these pathways alters the ability of a cell to control its proliferation as well as the initiation of programmed cell death (apoptosis).
Full Bio
Paul Spellman, Ph.D.
Associate Professor
spellmap@ohsu.edu
I am interested in using genetic, genomic, and proteomic data to understand and model the biology of cancer and to develop methods to effectively deploy therapeutic agents in the age of molecularly guided medicine.
Full Bio
H. Scott Stadler, Ph.D.
Associate Professor
hss@shcc.org
Our research ranges from biochemical identification of the DNA sequences preferred by individual HOX proteins to the development of therapeutics aimed at augmenting deficiencies in target gene expression caused by the loss of HOX protein function.
Full Bio
Anne Tsai, M.D., M.Sc., FAAP, FACMG
Associate Professor
tsaia@ohsu.edu
Dr. Anne Tsai specializes in caring for children with birth defects, developmental concerns, autism as well as any rare and inheritable diseases. Dr. Tsai joined OHSU in April of 2012 and comes from Denver where she practiced as a dysmorphologist and a Clinical Geneticist with the University of Colorado for 13 years.
Full Bio
Amanda Vinson, Ph.D.
Assistant Professor
vinsona@ohsu.edu
Heart disease has been described as a disease of low-grade, "smoldering" inflammation, and my research is aimed at understanding how genes and environmental influences contribute to inflammation in coronary heart disease.
Full Bio
Cari Wells, M.S., C.G.C.
Instructor
wellsc@ohsu.edu
We work with an incredibly diverse group of patients and families. My goal is to truly listen to each family's story and provide the most compassionate care I can.
Full Bio
Full Bio
